Texas Instruments: Remains A 'Hold' After Its Q2 Earnings

Texas Instruments (TXN) delivered strong Q2 2025 results, with revenue up 16% to $4.45 billion and EPS up 16% to $1.41, both at the high end of guidance, and returned $1.5 billion to shareholders. However, the stock dropped 13% post-earnings due to a cautious Q3 outlook, projecting 11% revenue growth but flat EPS, and management's perceived lack of reassurance. While acknowledging short-term headwinds and risks like China exposure and significant capex, the author maintains a "Hold" rating, emphasizing long-term conviction in TXN's strategic positioning for the semiconductor up-cycle, despite the current ~$190 share price exceeding their $150-$160 fair value estimate.

Analysis

Texas Instruments (TXN) presented a conflicting picture with its Q2 2025 results, reporting strong top- and bottom-line growth but issuing a cautious outlook that triggered a 13.3% share price decline. Revenue for the quarter rose 16% year-over-year to $4.45 billion and EPS grew 16% to $1.41, both at the high end of company guidance. The firm also returned $1.5 billion to shareholders via dividends and buybacks. However, this performance was overshadowed by a weak Q3 forecast, which projects an 11% revenue increase but flat EPS, coupled with management's unconvincing tone during the analyst call. Specific short-term headwinds include an expected sales slowdown in China, which grew 32% YoY in Q2, and a lagging recovery in the automotive sector. This near-term uncertainty contrasts with the company's aggressive long-term investment strategy, characterized by a heavy capex cycle ($5 billion in 2025) that is currently depressing free cash flow ($555 million vs. $1.3 billion net income in Q2). Key risks remain the company's significant exposure to China (around 20% of revenue) and the potential for over-investment in fabrication plants if demand forecasts prove too optimistic.

Key Decisions for Investors

• Given the stock is trading near $190, significantly above the analyst's fair value estimate of $150-$160, investors with a shorter time horizon may consider trimming positions due to the weak Q3 outlook and valuation disconnect.
• Long-term investors should closely watch the company's off-cycle presentation in August for any reaffirmation of its 2026 and beyond free cash flow targets, which is critical to justifying the current strategic capex plan.
• Monitor key risk factors including the impact of the heavy capex cycle on free cash flow conversion and any escalation in U.S.-China trade friction that could disrupt the 20% of revenue derived from China.
• For potential new investors, the $150-$160 range represents a more fundamentally supported entry point, suggesting patience is warranted until either the price corrects or Q3 results and future guidance mitigate current uncertainties.